BNP Paribas Financial Markets
NYMX

BNP Paribas Financial Markets’s Nymox Pharmaceutical Corp NYMX Stock Holding History

BNP Paribas Financial Markets’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-859
Closed -$163 – 4103
2023
Q2 		$163 Hold
859
– – ﹤0.01% 3838
2023
Q1 		$292 Sell
859
-344
-29% -$140 ﹤0.01% 3747
2022
Q4 		$389 Hold
1,203
– – ﹤0.01% 3882
2022
Q3 		$499 Sell
1,203
-397
-25% -$158 ﹤0.01% 4519
2022
Q2 		$696 Sell
1,600
-100
-6% -$92 ﹤0.01% 3935
2022
Q1 		$2.14K Hold
1,700
– – ﹤0.01% 3903
2021
Q4 		$2.21K Buy
1,700
+3
+0.2% +$5 ﹤0.01% 3987
2021
Q3 		$3.5K Sell
1,697
-500
-23% -$886 ﹤0.01% 3743
2021
Q2 		$3.47K Sell
2,197
-3,947
-64% -$7.32K ﹤0.01% 3830
2021
Q1 		$13.6K Sell
6,144
-254
-4% -$669 ﹤0.01% 3802
2020
Q4 		$15.9K Sell
6,398
-2,683
-30% -$5.93K ﹤0.01% 3879
2020
Q3 		$22.3K Buy
9,081
+7,592
+510% +$22.1K ﹤0.01% 3797
2020
Q2 		$5.29K Buy
1,489
+1,304
+705% +$4.12K ﹤0.01% 3983
2020
Q1 		$433 Hold
185
– – ﹤0.01% 4153
2019
Q4 		$407 Sell
185
-3,470
-95% -$6.85K ﹤0.01% 4264
2019
Q3 		$6.72K Hold
3,655
– – ﹤0.01% 4225
2019
Q2 		$5.3K Sell
3,655
-3,179
-47% -$5.56K ﹤0.01% 4236
2019
Q1 		$13.5K Buy
6,834
+6,003
+722% +$12.7K ﹤0.01% 3985
2018
Q4 		$1.09K Sell
831
-1,226
-60% -$2.25K ﹤0.01% 3908
2018
Q3 		$5.06K Buy
2,057
+480
+30% +$1.42K ﹤0.01% 4057
2018
Q2 		$5.3K Sell
1,577
-6,279
-80% -$24.1K ﹤0.01% 4077
2018
Q1 		$33.2K Sell
7,856
-196
-2% -$679 ﹤0.01% 3752
2017
Q4 		$26.6K Buy
8,052
+5,270
+189% +$19.2K ﹤0.01% 3908
2017
Q3 		$10.6K Sell
2,782
-206
-7% -$781 ﹤0.01% 3854
2017
Q2 		$13.1K Buy
+2,988
New +$12.3K ﹤0.01% 3866

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

BNP Paribas Financial Markets's NYMX Position: Q3 2023 in Review

BNP Paribas Financial Markets sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 859 shares — an estimated $163 sold.

BNP Paribas Financial Markets first reported a position in NYMX in Q2 2017 and held it in 25 quarters. The position peaked at $33.2K in Q1 2018. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • BNP Paribas Financial Markets reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 859 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $163.
  • BNP Paribas Financial Markets first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 25 quarters.
  • BNP Paribas Financial Markets's Nymox Pharmaceutical Corp position peaked at $33.2K in Q1 2018.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.